Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
General Infectious Disease
What is your preferred empiric antibiotic escalation for a patient with chorioamnionitis with worsening signs of sepsis on single agent cefoxitin?
Related Questions
Do you approach suppressive antibiotic therapy differently for patients with cardiac implant- able electronic devices infections compared to patients with LVAD related infections?
How do you approach patients who continue to experience pruritus and ongoing concern for persistent scabies despite having completed appropriate treatment?
How do you manage patients with scleroderma who present with finger ulcerations without other signs of soft tissue infection and MRI demonstrates potential concern for osteomyelitis?
Do you continue PJP prophylaxis indefinitely in patients on rituximab maintenance therapy?
What is the best way to manage close contacts of patients with invasive group A streptococcal infections to minimize the risk of disease transmission while considering the potential adverse effects of prophylactic antibiotics?
Do you use first generation cephalosporins to treat non-endovascular streptococcus mitis infections?
Do you treat complicated pneumonia with a drained empyema longer if Streptococcus anginosus is cultured, either in isolation or with other organisms, compared to cases in which it is not?
Do you routinely test for co-infection of other tick-borne illnesses in a patient who tests positive for Lyme, anaplasmosis, babesiosis, or ehrlichiosis?
Under what circumstance would you order dalbavancin instead of vancomycin or daptomycin for MRSA endocarditis?
Would you recommend early empirical anti-mold therapy for patients with severe influenza pneumonia admitted to the ICU to reduce the incidence of influenza-associated pulmonary aspergillosis?
